You are here

  • Home
  • Archive
  • Volume 11, Issue 1
  • Venous thromboembolism incidence and risk factors associated with immune checkpoint inhibitors among patients with advanced non-small cell lung cancer

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Venous thromboembolism incidence and risk factors associated with immune checkpoint inhibitors among patients with advanced non-small cell lung cancer

 

Online download statistics by month:

Online download statistics by month: January 2023 to March 2024

AbstractFullPdf
Jan 202340741594
Feb 202327327395
Mar 202320721176
Apr 202319619752
May 202314114258
Jun 202317317748
Jul 202312512551
Aug 202317517731
Sep 202312612643
Oct 2023959866
Nov 202310811250
Dec 202310610857
Jan 202410310673
Feb 2024717138
Mar 2024717170
Total23772409902